Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) EBIT: 2009-2019

Historic EBIT for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2019 value amounting to $72.3 million.

  • Neurocrine Biosciences' EBIT rose 200.45% to $44.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $94.5 million, marking a year-over-year decrease of 32.49%. This contributed to the annual value of $72.3 million for FY2019, which is 95.92% up from last year.
  • Neurocrine Biosciences' EBIT amounted to $72.3 million in FY2019, which was up 95.92% from $36.9 million recorded in FY2018.
  • Over the past 5 years, Neurocrine Biosciences' EBIT peaked at $72.3 million during FY2019, and registered a low of -$147.4 million during FY2016.
  • Over the past 3 years, Neurocrine Biosciences' median EBIT value was $36.9 million (recorded in 2018), while the average stood at -$7.4 million.
  • In the last 5 years, Neurocrine Biosciences' EBIT tumbled by 56.44% in 2016 and then skyrocketed by 128.09% in 2018.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' EBIT stood at -$94.2 million in 2015, then crashed by 56.44% to -$147.4 million in 2016, then climbed by 10.86% to -$131.4 million in 2017, then soared by 128.09% to $36.9 million in 2018, then soared by 95.92% to $72.3 million in 2019.